Politiparty
Politiparty

118th Congress Health

H.R. 4881: To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program.

Introduced

  1. Introduced (completed)Jul 25, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Jul 25, 2023

This bill limits cost-sharing for covered drugs under the Medicare prescription drug benefit and Medicare Advantage.

Specifically, for costs above the deductible but below the annual out-of-pocket threshold, the bill limits cost-sharing to the average net price of the drug (i.e., the average amount paid less any rebates) or the cash price (i.e., the price charged to an individual without insurance), whichever is lower.

The Government Accountability Office must report on the bill's implementation.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

1

Who scored on this bill

0 points earned

No member has earned points from it yet.

See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Nicole Malliotakis

History

  1. Jul 25, 2023Introduced in the House by Nicole Malliotakis.
Show the full action history (9 actions)
  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. Dec 6, 2023Committee Consideration and Mark-up Session Held
  3. Dec 6, 2023Ordered to be Reported (Amended) by the Yeas and Nays: 45 - 0.
  4. Dec 5, 2023Committee Consideration and Mark-up Session Held
  5. Nov 15, 2023Subcommittee Consideration and Mark-up Session Held
  6. Nov 15, 2023Forwarded by Subcommittee to Full Committee by Voice Vote.
  7. Jul 28, 2023Referred to the Subcommittee on Health.
  8. Jul 25, 2023Introduced in House
  9. Jul 25, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.